Magdalena Harrington, PhD
Magdalena Harrington is a subject matter expert in clinical outcomes assessment (COA) research with over 15 years of experience in delivering health outcomes strategies that demonstrate clinical and economic value of new medicines. She joined Pfizer in 2018 and is leading Patient-Centered Outcomes Assessment (PCOA) team of COA scientists, designing and implementing COA strategies for […]
Asia Williams, MPH
Asia Williams is a Program Officer at the National Academy of Medicine (NAM) Leadership Consortium Collaboration for a Learning Health System. In this role, she leads the Trust & Engagement Action Collaborative, which focuses on facilitating meaningful engagement and building trust with individuals, families, and communities on the health goals that matter most to them. […]
Carissa Escober Doran, PhD, MPA, BSN
Carissa Escober Doran, PhD, MPA, BSN is a research scientist in Health Economics and Outcomes Research (HEOR) at Vivo Health, Northwell Health’s pharmacy division, where she leads outcomes-based research. Having worked across nonprofit and industry settings for over a decade, Dr. Doran was a health economist at Avalere Health in life sciences consulting for the […]
C. Daniel Mullins, PhD
C. Daniel Mullins is a Professor at the University of Maryland School of Pharmacy. He is Founder and Executive Director of the University of Maryland PATient-centered Involvement in Evaluating effectiveNess of TreatmentS (PATIENTS) Program. He received his BS in Economics from M.I.T. and his PhD in Economics from Duke University. His research and teaching focus […]
Kimberly Westrich, MA
Kimberly Westrich, MA, is the Chief Strategy Officer of the National Pharmaceutical Council (NPC), which sponsors and conducts research on health policy issues related to the development and use of innovative biopharmaceuticals to improve the health of patients. NPC’s research contributes to the body of evidence that supports discussions and decisions about patient access to treatments, appropriate […]
Simu Thomas, PhD
Simu Thomas is the Vice President and Global Head of Health Economics & Outcomes Research, Global Medical Communications and Training at Alexion, AstraZeneca Rare Diseases. Simu brings 25 years of leadership experience in the areas of Value, HEOR, RWE and Access, building and leading capabilities across the world. Prior to Alexion, Simu held several […]
Richie Kahn, MPH
A health policy professional by training, clinical researcher by trade and patient advocate by necessity, Richie Kahn has spent the last 15 years working across the industry to reduce the time it takes to bring promising new treatments to the patients that need them most. As Co-Founder & COO of Canary Advisors, Richie partners with […]
Beth Gore, PhD
Beth Gore, PhD, is a national patient safety advocate, author and speaker who represents patients through patient associations, serving on boards, and being a voice of the patient on national committees and task forces with over a decade of direct vascular access and parenteral and enteral focus. She is the current Executive Director of The Oley […]
Harsha Rajasimha, PhD, MS
Harsha is a serial entrepreneur, postdoctoral data scientist trained at NIH, global patient advocate, and investor. As the founder and CEO of Jeeva Clinical Trials Inc.(https://jeevatrials.com), Harsha is pioneering an AI-driven unified platform for sponsors and CROs to execute patient-centric clinical trials with efficiency and universal accessibility. As the Founder & executive chair of the […]
Jessica Johnson, MPH
Jessica K. Johnson is the Director of Community Research & Engagement at the National Eczema Association (NEA). In this role she leads the strategic development, growth, and implementation of NEA’s survey research, real-world data activities and NEA’s Ambassador’s Program, connecting over 500 patient and caregiver members across the US to opportunities to share their valuable […]